Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Amiloride analogs inhibit L-type calcium channels and display calcium entry blocker activity.

Garcia ML, King VF, Shevell JL, Slaughter RS, Suarez-Kurtz G, Winquist RJ, Kaczorowski GJ.

J Biol Chem. 1990 Mar 5;265(7):3763-71.

3.

Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.

Felix JP, King VF, Shevell JL, Garcia ML, Kaczorowski GJ, Bick IR, Slaughter RS.

Biochemistry. 1992 Dec 1;31(47):11793-800.

PMID:
1332772
4.

Inhibition of sodium-calcium exchange in cardiac sarcolemmal membrane vesicles. 1. Mechanism of inhibition by amiloride analogues.

Slaughter RS, Garcia ML, Cragoe EJ Jr, Reeves JP, Kaczorowski GJ.

Biochemistry. 1988 Apr 5;27(7):2403-9.

PMID:
3382630
5.

Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin.

King VF, Garcia ML, Himmel D, Reuben JP, Lam YK, Pan JX, Han GQ, Kaczorowski GJ.

J Biol Chem. 1988 Feb 15;263(5):2238-44.

7.

Inhibition of sodium-calcium exchange in cardiac sarcolemmal membrane vesicles. 2. Mechanism of inhibition by bepridil.

Garcia ML, Slaughter RS, King VF, Kaczorowski GJ.

Biochemistry. 1988 Apr 5;27(7):2410-5.

PMID:
3260109
8.
9.

Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.

Campiani G, Fiorini I, De Filippis MP, Ciani SM, Garofalo A, Nacci V, Giorgi G, Sega A, Botta M, Chiarini A, Budriesi R, Bruni G, Romeo MR, Manzoni C, Mennini T.

J Med Chem. 1996 Jul 19;39(15):2922-38.

PMID:
8709127
11.

Characterization of the binding of [3H]SR 33805 to the slow Ca2+ channel in rat heart sarcolemmal membrane.

Chatelain P, Dewinkeleer P, Beaufort P, Meysmans L, Clinet M.

Eur J Pharmacol. 1994 Apr 15;267(2):151-60.

PMID:
8050476
12.

Inhibition of Na+/Ca2+ exchange in pituitary plasma membrane vesicles by analogues of amiloride.

Kaczorowski GJ, Barros F, Dethmers JK, Trumble MJ, Cragoe EJ Jr.

Biochemistry. 1985 Mar 12;24(6):1394-403.

PMID:
2580553
13.

A novel high affinity class of Ca2+ channel blockers.

Qar J, Barhanin J, Romey G, Henning R, Lerch U, Oekonomopulos R, Urbach H, Lazdunski M.

Mol Pharmacol. 1988 Apr;33(4):363-9.

PMID:
2965787
14.

Incorporation of calcium channels from cardiac sarcolemmal membrane vesicles into planar lipid bilayers.

Ehrlich BE, Schen CR, Garcia ML, Kaczorowski GJ.

Proc Natl Acad Sci U S A. 1986 Jan;83(1):193-7.

15.

Mechanism of Ca(2+)-dependent inactivation of L-type Ca2+ channels in GH3 cells: direct evidence against dephosphorylation by calcineurin.

Victor RG, Rusnak F, Sikkink R, Marban E, O'Rourke B.

J Membr Biol. 1997 Mar 1;156(1):53-61.

PMID:
9070464
16.

Insulin-like growth factor-1 exerts Ca2+-dependent positive inotropic effects in failing human myocardium.

von Lewinski D, Voss K, Hülsmann S, Kögler H, Pieske B.

Circ Res. 2003 Feb 7;92(2):169-76.

17.
18.
19.

Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.

Akizuki O, Inayoshi A, Kitayama T, Yao K, Shirakura S, Sasaki K, Kusaka H, Matsubara M.

Eur J Pharmacol. 2008 Apr 28;584(2-3):424-34. doi: 10.1016/j.ejphar.2008.02.001. Epub 2008 Feb 12.

PMID:
18331727
20.

Mechanisms of Ca2+ transport in plasma membrane vesicles prepared from cultured pituitary cells. I. Characterization of Na+/Ca2+ exchange activity.

Kaczorowski GJ, Costello L, Dethmers J, Trumble MJ, Vandlen RL.

J Biol Chem. 1984 Aug 10;259(15):9395-403.

Supplemental Content

Support Center